18 multiple-sequence-alignment Postdoctoral positions at University of Florida in Postdoctoral
-
approaches to design highly selective therapeutics from only genome sequence. Known for its prolific output and pioneering research culture, the group has furthered advancements in annotating RNA structure
-
-resolution microscopy, single-cell RNA sequencing (scRNA-seq), and spatial transcriptomics. • Scientific Leadership: Independently manage project milestones, draft high-impact manuscripts, present findings
-
, DNA/RNA extraction, Sanger and amplicon sequencing, and analysis of editing outcomes. Track record of first-author peer-reviewed publications. Strong written and oral communication in English, and the
-
Description: The Postdoctoral Research Associate will support a collaborative research project focused on developing a collagen reference library for Florida vertebrates and investigating collagen sequence
-
-centered care, and mobile health. The position will support multiple studies spanning a variety of clinical and public health topics, such as patient engagement, clinical decision support, HIV care, and
-
on multiple funded projects focused on quantitative research methods development and/or the causal evaluation of educational programs. This is a 12-month, time-limited appointment. The appointment is renewable
-
approaches for analyzing sequencing datasets will be an added advantage. The candidates will have a track record of publishing in peer-reviewed academic journals and strong communication and problem-solving
-
, such as using Microsoft Office products, Chemdraw, and pymol viewer. Expected Salary: Commensurate with experience, aligned with NIH scale. Required Qualifications: An organic or Medicinal chemistry degree
-
environment is team-based science. We feature a highly collaborative environment and often take on ambitious projects that integrate the skills and abilities of multiple scientific fields. As such, strong
-
. The project focuses on development of novel immunotherapies to treat autoimmune disease, with an emphasis on Multiple Sclerosis. We are particularly interested in developing new AAV vectors to establish immune